As you are aware, the department of Health and Human Services has placed therapeutic monoclonal antibodies (i.e. REGEN-COV, bamlanivimab/etesevimab) to treat COVID-19 infection on a state-administered allocation. The Ohio Department of Health will allocate supply weekly to hospitals and health systems based on case count and supply availability.
Based on estimated allocation, current usage, and supply on hand, we regret to inform you that COVID-19 monoclonal antibodies (REGEN-COV, bamlanivimab/etesvimab) will be unavailable at freestanding emergency departments effective immediately until further notice.
Patients may receive COVID-19 monoclonal antibody treatment (REGEN-COV, bamlanivimab/etesvimab) at the following facilities dependent on available supply:
- Kettering COVID Infusion Center
- Kettering Health Dayton (formerly Grandview Medical Center)
- Kettering Health Greene Memorial (formerly Greene Memorial Hospital)
- Kettering Health Hamilton (formerly Fort Hamilton Hospital)
- Kettering Health Main Campus (formerly Kettering Medical Center)
- Kettering Health Miamisburg (formerly Sycamore Medical Center)
- Kettering Health Troy (formerly Troy Hospital)
- Kettering Health Washington Township (formerly Southview Medical Center)
- Soin Medical Center
Kettering Health will continue to reevaluate this decision at regular intervals and provide updates as appropriate.